Considering the crucial role of PI3K/mTOR/Akt signaling in cancer initiation, progression and metastatization, some inhibitors of this pathway have been tested and afterwards included in the therapeutic strategy of various cancer types. This evidence concerns the gene AKT1 and cancer.